Lung Transplant With Cardiopulmonary Bypass: Impact of Blood Transfusion on Rejection, Function, and Late Mortality

Article ID	Journal	Published Year	Pages	File Type
2871661	The Annals of Thoracic Surgery	2016	8 Pages	PDF

Abstract

All blood products administration regardless of amount transfused did not appear to affect early rejection outcomes or forced expiratory volume in 1 second expressed as percentage of forced vital capacity at 3 and 6 months. Use of RBC and FFP had no effect on survival. However, greater platelet usage appeared to adversely affect early but not late mortality.

Keywords

FEV1 CPB ABT TRIM RBC PGD FFP Red blood cells FEV1%primary graft dysfunction Allogeneic blood transfusion Transfusion-related immunomodulation cardiopulmonary bypass cytomegalovirus CMV confidence interval forced expiratory volume in 1 second hazard ratio fresh frozen plasma

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

Lung Transplant With Cardiopulmonary Bypass: Impact of Blood Transfusion on Rejection, Function, and Late Mortality

Authors

Lay Ping MB BChir, Ashwin MBBS, Bandigowdanapalya Channaiah MBBS, Hazel Muse, Kirstie Wallace, Gareth FRCP, MD, Stephen C. MBBS, MD,